Prognostic Utility of Minimal Residual Disease (MRD) after Curative Intent Induction Therapy for DLBCL: A Prospective Real-World Ctdna Study Sworder, B. J., Yoon, S., Kim, S., Schultz, A., Hogan, G., Close, S., Chabon, J. J., Diehn, M., Kurtz, D. M., Alizadeh, A. A., Kim, W. AMER SOC HEMATOLOGY. 2023

View details for DOI 10.1182/blood-2023-187650

View details for Web of Science ID 001159306700070